The activation of CEBPD has been observed in many autoimmune and age-associated chronic inflammation diseases, such as atherosclerosis [63], type 2 diabetes [64], rheumatoid arthritis (RA) [65], Alzheimer’s disease (AD) [66] and Parkinson’s disease [67]. This evidence concerns the gene CEBPD and Alzheimer disease.